Docetaxel plus prednisolone for the treatment of metastatic hormone-refractory prostate cancer: a multicenter Phase II trial in Japan.
暂无分享,去创建一个
H. Akaza | S. Naito | T. Tsukamoto | T. Harabayashi | Y. Sumiyoshi | H. Koga | S. Hoshi | T. Tsukamoto | H. Koga